Who is sponsoring NCT05368675?

NCT05368675 is sponsored by University of Pennsylvania.

What drugs are being tested in NCT05368675?

Interventions in NCT05368675: medication for opioid use disorder.

What condition does NCT05368675 study?

NCT05368675 studies Opioid Use Disorder, HIV Infections.

Is NCT05368675 still recruiting?

NCT05368675 is currently completed. Last updated 10 May 2022.

Last reviewed 2022-05-10 · How we verify

NCT05368675: OIT-HCMC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medication-assisted Treatment for Injecting Drug Users in Vietnam

Completed Phase 4 Last updated 10 May 2022

What this trial tests

Phase 4 trial testing medication for opioid use disorder in Opioid Use Disorder in 448 participants. Completed in 31 August 2018.

Timeline

18 December 2013

Primary endpoint
31 August 2017

31 August 2018

Quick facts

Lead sponsor	University of Pennsylvania
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	448
Start date	18 December 2013
Primary completion	31 August 2017
Estimated completion	31 August 2018

Drugs / interventions tested

medication for opioid use disorder — full drug profile →

Conditions studied

Opioid Use Disorder — all drugs for Opioid Use Disorder →
HIV Infections — all drugs for HIV Infections →

Sponsor

University of Pennsylvania

Who can join

18 and older, any sex, with Opioid Use Disorder or HIV Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

HIV continues to spread around the world and new infections in Asia are one of the most important areas for prevention among drug using populations. There is strong and consistent evidence from several countries that while injection drug users (IDU) continue to be a source of new infections, treatment of opiate addiction is an effective prevention measure against further spread. The project evaluated the implementation of a comprehensive opioid use disorder treatment program co-located with an HIV clinic in Ho Chi Minh City, Vietnam. The program includes medication for opioid use disorder (methadone, buprenorphine/naloxone), standardized counseling sessions (BDRC) and HIV testing and care (for people living with HIV).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Opioid Use Disorder

Currently open trials in the same condition.

NCT07278518 — Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine · NA · recruiting
NCT07044466 — Social Functioning in Opioid Use Disorder · NA · recruiting
NCT07158853 — Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder · NA · recruiting
NCT06943859 — Ketamine for Opioid Use Disorder · Phase 2 · recruiting
NCT06651177 — Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder · Phase 2 · recruiting

Other University of Pennsylvania trials

Trials by the same sponsor.

NCT06081153 — Mechanistic Clinical Trial of PCSK9 Inhibition for AAA · EARLY_PHASE1 · not yet recruiting
NCT07415772 — Effect of cTBS on Startle and TMS-evoked BOLD · NA · not yet recruiting
NCT07489430 — DaxibotulinumtoxinA for Blepharospasm · Phase 2 · not yet recruiting
NCT07463131 — Negative Income Tax Trial · NA · not yet recruiting
NCT06645769 — Na-Phenylbutyrate VAscular Trial · EARLY_PHASE1 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05368675 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Pennsylvania
Last refreshed: 10 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05368675.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing